Allena Pharmaceuticals Inc. (ALNA) Return on Investment ROI from the second quarter of 2022 to second quarter of 2021 and for the year 2022, average high and low, overall ranking from Jun 30 2022 to Jun 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Allena Pharmaceuticals Inc.  (NASDAQ: ALNA)


Allena Pharmaceuticals's ROI from its second quarter of 2022 to the second quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Allena Pharmaceuticals's ROI in the second quarter of 2022?
Allena Pharmaceuticals Inc. recorded a cumulative net loss of $-43 million during 12 months ending in the second quarter of 2022, resulting in a negative return on investment (ROI) of -234.73%.

Within the Healthcare sector 1036 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2022 from 0 to 5221.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter
Y / Y Investment Change TTM -36.38 % -23.79 % 12 % 38.78 % 24.21 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 7 12 19 36 22
Return On Investment (TTM) -234.73 % -220.61 % -176.47 % -156.82 % -151.37 %
ALNA's Overall Ranking # 5221 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -16.67 % -19.72 % -10.94 % 6.79 % -0.19 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -43 -49 -49 -49 -44

ALNA Company Profile >> Back to ALNA Roi Comparisons >> See Annual ALNA Return On Investment



Return On Investment ALNA's Ranking
Within: No.
Industry # 164
Sector # 1037
Overall # 5221

Return On Investment Statistics
High Average Low
-27.15 %
-125.4 %
-233.2 %
(Sep 30 2018)   (Jun 30 2022)







Financial Statements
Allena Pharmaceuticals's II. Quarter Investments $ 7 Millions ALNA's Balance sheet
Allena Pharmaceuticals's II. Quarter Income $ -8 Millions Quarterly ALNA's Income Statement
ALNA's Income by Division See ALNA's Income by Division


ALNA Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 19 32 23 59 89
Y / Y Investment Growth -41.8 % 39.83 % -61.01 % -32.96 % -
Net Income in Millions -49 -33 -47 -36 -22
Y / Y Net Income Growth - - - - -
Annual Return On Investment -257.91 % -101.3 % -204.17 % -59.95 % -24.41 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ALNA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ALNA's Competitors
Subscribers only: Roi for Allena Pharmaceuticals's Suppliers
Subscribers only: Return On Investment for ALNA's Customers

Other Ratios
ALNA's Roa ALNA's Inventory Turnover Ratio ALNA's Growth Rates ALNA's Dividend Statistics
ALNA's Profitability Ratios ALNA's Asset Turnover Ratio ALNA's Dividend Growth
ALNA's Roe ALNA's Valuation Ratios ALNA's Financial Strength Ratios ALNA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2022, within Healthcare Sector ROI

Date modified: 2026-08-29T17:38:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.